Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms

Elizabeth A Grunfeld; Amber Halliday; Pauline Martin; Lawrence Drudge-Coates

doi:10.1097/NCC.0b013e318211fa92

Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms

Elizabeth A Grunfeld, Amber Halliday, Pauline Martin, Lawrence Drudge-Coates

Psychology

Research output: Contribution to journal › Article › peer-review

30 Citations (Scopus)

Abstract

Androgen deprivation therapy (ADT) has become the cornerstone of treatment for men with metastatic prostate cancer. However, treatments are associated with a number of adverse effects that collectively are referred to as andropause syndrome, or the male menopause.

Original language	English
Pages (from-to)	63-9
Number of pages	7
Journal	Cancer Nursing
Volume	35
Issue number	1
DOIs	https://doi.org/10.1097/NCC.0b013e318211fa92
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/NCC.0b013e318211fa92

Cite this

@article{cca388e2f5134cfeaf8b1ea907245794,

title = "Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms",

abstract = "Androgen deprivation therapy (ADT) has become the cornerstone of treatment for men with metastatic prostate cancer. However, treatments are associated with a number of adverse effects that collectively are referred to as andropause syndrome, or the male menopause.",

author = "Grunfeld, {Elizabeth A} and Amber Halliday and Pauline Martin and Lawrence Drudge-Coates",

year = "2012",

doi = "10.1097/NCC.0b013e318211fa92",

language = "English",

volume = "35",

pages = "63--9",

journal = "Cancer Nursing",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Andropause syndrome in men treated for metastatic prostate cancer

T2 - a qualitative study of the impact of symptoms

AU - Grunfeld, Elizabeth A

AU - Halliday, Amber

AU - Martin, Pauline

AU - Drudge-Coates, Lawrence

PY - 2012

Y1 - 2012

N2 - Androgen deprivation therapy (ADT) has become the cornerstone of treatment for men with metastatic prostate cancer. However, treatments are associated with a number of adverse effects that collectively are referred to as andropause syndrome, or the male menopause.

AB - Androgen deprivation therapy (ADT) has become the cornerstone of treatment for men with metastatic prostate cancer. However, treatments are associated with a number of adverse effects that collectively are referred to as andropause syndrome, or the male menopause.

U2 - 10.1097/NCC.0b013e318211fa92

DO - 10.1097/NCC.0b013e318211fa92

M3 - Article

C2 - 21558849

VL - 35

SP - 63

EP - 69

JO - Cancer Nursing

JF - Cancer Nursing

IS - 1

ER -

Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this